Biogen (BIIB)

R&D Expense Growth

-13.51%

Quarterly · Period ending:

BIIB logo

BIIB R&D Expense Growth

Latest reported-13.51%
BIIB Quarterly R&D Growth (QoQ) (0.00% → -13.51%)
High-resolution chart · PNG

BIIB r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
8.7234%
-1.1747%
-22.0777%
31.7945%
13.8003%
4.5691%
2.1237%
15.9136%
-0.1961%
4.2348%
-0.3503%
16.6271%
13.4771%
-3.6389%
4.0568%
15.625%
-15.5673%
-21.3432%
58.5%
3.7543%
19.5918%
5.3854%
3.3244%
5.6338%
4.4118%
8.4357%
-17.4868%
-13.308%
12.8755%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.